In vivo bromodeoxyuridine labelling index, AgNOR protein expression and DNA content in human tumours

European Journal of Histochemistry

Volumn 40, Issue 1, 1996, Pages 17-26

  Trere D ^a   Ceccarelli, C ^a   Danova, M ^b   Derenzini, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

AgNOR proteins; DNA content; human tumours; in vivo BrdU LI; S phase fraction

Indexed keywords

BROXURIDINE; CELL NUCLEUS ANTIGEN; DNA; NUCLEAR PROTEIN; NUCLEOLAR ORGANIZER REGION ASSOCIATED PROTEINS; TRANSCRIPTION FACTOR;

ANEUPLOIDY; ARTICLE; BIOSYNTHESIS; CELL DIVISION; CHROMOSOME NOR; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; REGRESSION ANALYSIS; SILVER STAINING; STATISTICAL MODEL;

ANEUPLOIDY; ANTIGENS, NUCLEAR; BROMODEOXYURIDINE; CELL DIVISION; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LINEAR MODELS; MALE; NEOPLASMS; NUCLEAR PROTEINS; NUCLEOLUS ORGANIZER REGION; REGRESSION ANALYSIS; SILVER STAINING; TRANSCRIPTION FACTORS;

EID: 0029744621     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Aubele M, Auer G, Gais P, Jutting U, Rodenacker K, and Voss A.: Nucleolar organizer regions (AgNORs) in ductal mammary carcinoma. Comparison with classifications and prognosis. Pathol. Res. Pract. 1994, 190, 129-137.
2. Brookes CN, Ooms BC, McGill F, England K, Hinchliffe SA, and van Velzen D.: Ploidy independence of Ag-NOR number in neuroblastoma. Lab. Invest. 1992, 67, 243-245.
3. Carbajo-Perez E, Alberca V, Vicente-Villardon V, Flores T, and Carbajo S.: Expression of argyrophilic nucleolar organizer regions (AgNORs) can be used to assess cellular proliferation as shown in rat thymic sections. Histochem. J. 1993, 25, 548-553.
4. Charpin C, Bonnier P, Piana L., et al.: Correlation of nucleolar organizer regions and nuclear morphometry assessed by automatic image analysis in breast cancer with aneuploidy, Ki67 immunostaining, histopathologic grade and lymph node involvement. Pathol. Res. Pract. 1992, 188, 1009-1017.
5. Crocker J, Macartney JC, and Smith PJ.: Correlation between DNA flow cytometric and nucleolar organizer region data in non- Hodgkin's lymphomas. J. Pathol. 1988, 154, 151-56.
6. Danova M, Giaretti W, Merlo F., et al.: Prognostic significance of nuclear DNA content in human neuroepithelial tumors. Int. J. Cancer. 1991, 48, 663-667.
7. Danova M, Riccardi A, Brugnatelli S., et al.: In vivo bromodeoxyuridine incorporation in human gastric cancer: a study on formalin-fixed and paraffin-embedded sections. Histochemical J. 1988, 20, 125-130.
8. Derenzini M., Pession A., Farabegoli F., Trerè D., Badiali M., and Dehan P.: Relationship between interphasic nucleolar organizer regions and growth rate in two neuroblastoma cell lines. Am. J. Pathol. 1989, 134, 925-932.
9. Derenzini M., Pession A., and Trerè D.: The quantity of nucleolar silver-stained proteins is related to proliferating activity in cancer cells. Lab. Invest. 1990, 63, 137-140.
10. Derenzini M., and Ploton D.: Interphase nucleolar organizer regions in cancer cells. Int. Rev. Exp. Pathol. 1991, 32, 149-192.
11. Derenzini M., Sirri V., and Trerè D.: Nucleolar organizer regions in tumor cells. J. Cancer 1994, 7, 71-77.
12. Derenzini M, Trerè D, Chieco P, and Melchiorri C.: Interphase AgNOR quantity is not related to DNA content in 11 established human cancer cell lines. Exp. Cell. Res. 1994, 211, 282-285.
13. Derenzini M., and Trerè D.: Importance of interphase nucleolar organizer regions in tumor pathology. Virchows. Arch. B. Cell. Pathol. 1991, 61, 1-8.
14. Dervan P.A., Gilmartin L.G., Loftus B.M., and Carney DN.: Breast carcinoma kinetics. Argyrophilic nucleolar organizer region counts correlate with Ki67 scores. Am. J. Clin. Pathol. 1989, 92, 401-407.
15. Dolbeare F., Gratzner H., Pallavicini M.G., and Gray J.W.: Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc. Natl. Acad. Sci. USA 1983, 80, 5573-5577.
16. Giri D.D., Nottingham J.F., Lawry J., Dundas S.A., and Underwood J.C.: Silver-binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: correlations with ploidy and growth phase by DNA flow cytometry. J. Pathol. 1989, 157, 307-313.
17. Goz B.: The effects of incorporation of 5-halogenated deoxyuridines into DNA of eukaryotic cells. Pharmacol. Rev. 1977, 29, 249-272.
18. Gratzner H.G.: Monoclonal antibody to 5-bromo and 5-iodo- deoxyuridine. A new reagent for detection of DNA replication. Science 1982, 218, 474-475.
19. Hall P.A., Crocker J., Watts A., and Stansfeld AG.: A comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin's lymphoma. Histopathol. 1988, 12, 373-381.
20. Hara A., Hirayama H., Sakai N., Yamada H., Tanaka T., and Mori H.: Correlation between nucleolar organizer region staining and Ki-67 immunostaining in human gliomas. Surg. Neurol. 1990, 33, 320-324.
21. Hara A., Niikawa S., Hirayama H., et al : Correlation between nucleolar organizer region score and bromodeoxyuridine labelling index in C6 glioma cell line. J. Neuro. Oncol. 1991, 11, 149-155.
22. Kakeji Y., Korenaga D., Tsujitani S., Haraguchi M., Maehara Y., and Sugimachi K.: Predictive value of Ki-67 and argyrophilic nucleolar organizer region staining for lymph node metastasis in gastric cancer. Cancer Res. 1991, 51, 3503-3506.
23. Kuratsu S., Aozasa K., Myoui A., et al.: Prognostic significance of argyrophilic nucleolar organizer staining in soft-tissue sarcomas. Int. J. Cancer 1991, 48, 211-214.
24. Leek R.D., Alison MR., and Sarraf C.E.: Variations in the occurrence of silver-staining nucleolar organizer regions (AsNORs) in non- proliferating and proliferating tissues. J. Pathol. 1991, 165, 43-51.
25. Mourad W.A., Erkman-Balis B., Livingston S., et al.: Argyrophilic nucleolar organizer regions in breast carcinoma. Correlation with DNA flow cytometry, histopathology, and lymph node status. Cancer 1992, 69, 1739-1744.
26. Mourad W.A., Connelly J.H., Sembera D.L., Atkinson E.N., and Bruner J.M.: The correlation of two argyrophilic nucleolar organizer region counting methods with bromodeoxyuridine-labelling index: a study of metastatic tumours of the brain. Hum. Pathol. 1993, 24, 206-210.
27. Morita M., Kuwano H., Matsuda H., Moriguchi S., and Sugimachi K.: Prognostic significance of argyrophilic nucleolar organizer regions in esophageal carcinoma. Cancer Res. 1991, 51, 5339-5341.
28. Nakamura S., Takeda Y., Okabe Y., et al.: Argyrophilic proteins of the nucleolar organizer regions in acute leukemias and its relations to the S-phase fraction of leukemic cells. Acta. Haematol. 1992, 87, 6-10.
29. Öfner D., Hittmair A., Marth C., Öfner C., Totsch M., and Daxenbichler G.: Relationship between quantity of silver stained nucleolar organizer region associated proteins (AgNORs) and population doubling time in ten breast canceircell lines. Pathol. Res. Pract. 1992, 188, 742-746.
30. Orita T., Kajiwara K., Nishizaki T., Ikeda N., Kamiryo T., and Aoki H.: Nucleolar organizer regions in meningioma. Neurosurgery 1990, 26, 43-46.
31. Plate K.H., Arndt D., Hellwig D., Rüschoff J., and Mennel H.D.: Assessment of histogenesis and proliferative potential in cytologic specimens of human brain tumors. Value of immunocytochemistry and nucleolar organizer regions. Anal. Quant. Cytol. Histol. 1990, 12, 157-164.
32. Pich A., Chiusa L., Pisani P., Krengli M., Pia F., and Navone R.: Argyrophilic nucleolar organizer region counts and proliferating cell nuclear antigen scores are two reliable indicators of survival in pharyngeal carcinoma. J. Cancer Res. Clin. Oncol. 1992, 119, 106-110.
33. Ploton D., Menager M., Jeannesson P., Himber G., Pigeon F., and Adnet J.J.: Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem. J. 1986, 18, 5-14.
34. Quinn C.M., and Wright N.A.: The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables. J. Pathol. 1990, 161, 93- 102.
35. Raymond W.A., and Leong A.S.: Nucleolar organizer regions relate to growth fractions in human breast carcinoma. Hum. Pathol. 1989, 20, 741-746.
36. Riccardi A., Danova M., Wilson G., et al.: Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry. Cancer Res. 1988, 48, 6238-6245.
37. Risio M., and Rossini FP.: Cell proliferation of colorectal adenomas containing invasive carcinomas. Anticancer Res. 1993, 13, 43-47.
38. Rosa J., Mehta A., and Filipe M.I.: Nucleolar organizer regions, proliferative activity and DNA index in gastric carcinomas. Histopathology 1990, 16, 614-616.
39. Rüschoff J., Neumann K., Contractor H., Plate K., and Thomas C.: Assessment of nucleolar organizer regions by automatic image analysis in breast cancer: correlation with DNA content, proliferation rate, receptor status and histopathological grading. J. Cancer Res. Clin. Oncol. 1990, 116, 480-485.
40. Santini D., Ceccarelli C., Mazzoleni G., Pasquinelli G., Jasonni V.M., and Martinelli G.N.: Demonstration of cytocheratin intermediate filaments in oocytes of the developing and adult human ovary. Histochemistry 1993, 99, 311-319.
41. Sasaki K., Matsumura K., Murakami K., and Tsuji T.: Measurement of bromodeoxyuridine labelling index, Ki-67 score and AgNOR count in breast carcinomas. Oncology 1992, 49, 147-153.
42. Sasaki K., Matsumura K., Tsuji T., Shinozaki F., and Takahashi M.: Relationship between labelling indices of Ki-67 and BrdUrd in human malignant tumors. Cancer 1988, 62, 989-993.
43. Scucchi L., Silecchia G., Di Stefano D., et al.: Interphasic nucleolar organizer regions expression and cell kinetics evaluation during gastric carcinogenesis induced by nitrosoguanidine in the rat. Virchows. Arch. B. Cell. Pathol. 1992, 62, 303-309.
44. Shibuya M., Ito S., Miwa T., Davis R.L., Wilson C.B., and Hoshino T.: Proliferative potential of brain tumors. Analyses with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nuclear organizer region counts. Cancer 1993, 71, 199-206.
45. Skopelitou A., Korkolopoulou P., Papanicolaou A., Christodoulou P., Thomas-Tsagli E., and Pavlakis K.: Comparative assessment of proliferating cell nuclear antigen immunostaining and of nucleolar organizer region staining in transitional cell carcinomas of the urinary bladder. Correlation with other conventional prognostic pathologic parameters. Eur. Urol. 1992, 22, 235-240.
46. Tanaka T., Kojima T., Suzui M., and Mon H.: Chemoprevention of colon carcinogenesis by natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis. Cancer Res. 1993, 53, 3908-3913.
47. Trerè D.: Critical analysis of the methods commonly employed in the assessment of cell proliferation: advantages of the NOR silver-staining technique in routine cytohistopathology. Anal. Cell. Pathol. 1993, 5, 191-201.
48. Trerè D., Farabegoli F., Cancellieri A., Ceccarelli C., Eusebi V., and Derenzini M.: AgNOR area in interphase nuclei of human tumours correlates with the proliferative activity evaluated by bromodeoxyuridine labelling and Ki-67 immunostaining. J. Pathol. 1991, 164, 53-59.
49. Trerè D., Melchiorri C., Chieco P., Marabini A., and Derenzini M.: AgNOR protein quantity and DNA content in endometrial carcinoma. Gynecol. Oncol. 1994, 53, 202-207.
50. Trerè D., Migaldi M., and Trentin G.P.: Higher reproducibility of morphometric analysis over the counting method for AgNOR protein quantification. Anal. Cell. Pathol. 1994, in press.
51. Trerè D., Pession A., and Derenzini M.: The silver-stained proteins of interphasic nucleolar organizer regions as a parameter of cell duplication rate. Exp. Cell. Res. 1989, 184: 131-137.